Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.
Deal News - GreenGate Partners advised the shareholders of deviceTRUST GmbH on the sale to Cloud Software Group
GreenGate Partners has successfully advised the shareholders of deviceTRUST GmbH on the sale of their shares to Cloud Software Group Germany GmbH.
The acquisition means that Citrix, a business unit of Cloud Software Group, is expanding its offerings to include deviceTRUST’s innovative security solutions.
deviceTRUST offerings are leading context-aware security solutions that enable organizations to securely design hybrid work environments. The planned integration into the Citrix platform will strengthen zero-trust access control and enable organizations to control access to applications and data even more precisely based on device posture and user context.
More Deal News
13. Januar 2025
Secondary Private Equity und Private Debt: Tobias Schönhaar im Gespräch mit dem VC-Magazin
9. Dezember 2024
Deal News – GreenGate Partners advises Boehringer Ingelheim Venture Fund (BIVF) on EUR 9.1 Mio. seed-extension financing round of Refoxy Pharma GmbH
6. Dezember 2024
Deal News – GreenGate Partners advises Nauta Capital and InReach Ventures on EUR 4 Mio. series seed financing round of NetBird GmbH
Advisors GreenGate Partners
Dr. Tobias Schönhaar, LL.M. (Bond) (Lead / Partner / Corporate)
René Spitz LL.M. (USC) (Partner/Corporate) (Lead)
Constantin Forstner (Associate/Corporate)
Carl von Sydow (Associate/Corporate)
Dr. Jens Ginal (Partner / Employment)
Dr. Alexander Raif (Partner / Employment)
Alexander Tribess (Partner / IT, IP)
Paul Harloff (Associate / IT & Data Protection)
Tobias Perchermeier (Associate / Data Protection and General Commercial Law)
Dr. Sven Schilf (Partner/IP, IT & Life Sciences)
Lenz Hesse (Associate/IP, IT & Life Sciences)